98 related articles for article (PubMed ID: 12642868)
1. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K
Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.
Kim HR; Park HJ; Park JH; Kim SJ; Kim K; Kim J
Cancer Immunol Immunother; 2004 May; 53(5):461-70. PubMed ID: 14648068
[TBL] [Abstract][Full Text] [Related]
3. CASC2/miR-24/miR-221 modulates the TRAIL resistance of hepatocellular carcinoma cell through caspase-8/caspase-3.
Jin X; Cai L; Wang C; Deng X; Yi S; Lei Z; Xiao Q; Xu H; Luo H; Sun J
Cell Death Dis; 2018 Feb; 9(3):318. PubMed ID: 29476051
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.
Herbeuval JP; Nilsson J; Boasso A; Hardy AW; Kruhlak MJ; Anderson SA; Dolan MJ; Dy M; Andersson J; Shearer GM
Proc Natl Acad Sci U S A; 2006 May; 103(18):7000-5. PubMed ID: 16632604
[TBL] [Abstract][Full Text] [Related]
5. Effect of interferon-gamma on the susceptibility to Fas (CD95/APO-1)-mediated cell death in human hepatoma cells.
Shin EC; Shin WC; Choi Y; Kim H; Park JH; Kim SJ
Cancer Immunol Immunother; 2001 Mar; 50(1):23-30. PubMed ID: 11315506
[TBL] [Abstract][Full Text] [Related]
6. Interferon-β Overexpression in Adipose Tissue-Derived Stem Cells Induces HepG2 and Macrophage Cell Death in Liver Tumor Organoids via Induction of TNF-Related Apoptosis-Inducing Ligand Expression.
Yoon Y; Kim CW; Kim MY; Baik SK; Jung PY; Eom YW
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279326
[TBL] [Abstract][Full Text] [Related]
7. Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion.
Pallavi R; Gatti E; Durfort T; Stendardo M; Ravasio R; Leonardi T; Falvo P; Duso BA; Punzi S; Xieraili A; Polazzi A; Verrelli D; Trastulli D; Ronzoni S; Frascolla S; Perticari G; Elgendy M; Varasi M; Colombo E; Giorgio M; Lanfrancone L; Minucci S; Mazzarella L; Pelicci PG
Nat Commun; 2024 Jan; 15(1):828. PubMed ID: 38280853
[TBL] [Abstract][Full Text] [Related]
8. Enhancer Clusters Drive Type I Interferon-Induced TRAIL Overexpression in Cancer, and Its Intracellular Protein Accumulation Fails to Induce Apoptosis.
Di Benedetto C; Khan T; Serrano-Saenz S; Rodriguez-Lemus A; Klomsiri C; Beutel TM; Thach A; Walczak H; Betancur P
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765925
[TBL] [Abstract][Full Text] [Related]
9. Interferon-α and its effects on cancer cell apoptosis.
Shi W; Yao X; Fu Y; Wang Y
Oncol Lett; 2022 Jul; 24(1):235. PubMed ID: 35720476
[TBL] [Abstract][Full Text] [Related]
10. A combined antitumor strategy of separately transduced mesenchymal stem cells with soluble TRAIL and IFNβ produces a synergistic activity in the reduction of lymphoma and mice survival enlargement.
Quiroz-Reyes AG; González-Villarreal CA; Martínez-Rodriguez H; Said-Fernández S; Salinas-Carmona MC; Limón-Flores AY; Soto-Domínguez A; Padilla-Rivas G; Montes De Oca-Luna R; Islas JF; Garza-Treviño EN
Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35485288
[TBL] [Abstract][Full Text] [Related]
11. Recent Progress in Interferon Therapy for Myeloid Malignancies.
Healy FM; Dahal LN; Jones JRE; Floisand Y; Woolley JF
Front Oncol; 2021; 11():769628. PubMed ID: 34778087
[TBL] [Abstract][Full Text] [Related]
12. The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer.
Ustyanovska Avtenyuk N; Visser N; Bremer E; Wiersma VR
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105656
[TBL] [Abstract][Full Text] [Related]
13. CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death.
Chung AH; Leisner TM; Dardis GJ; Bivins MM; Keller AL; Parise LV
Cancer Cell Int; 2019; 19():26. PubMed ID: 30740034
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NF-κB Pathway and Modulation of MAPK Signaling Pathways in Glioblastoma and Implications for Lovastatin and Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) Combination Therapy.
Liu PC; Lu G; Deng Y; Wang CD; Su XW; Zhou JY; Chan TM; Hu X; Poon WS
PLoS One; 2017; 12(1):e0171157. PubMed ID: 28135339
[TBL] [Abstract][Full Text] [Related]
15. Interferon α Induces the Apoptosis of Cervical Cancer HeLa Cells by Activating both the Intrinsic Mitochondrial Pathway and Endoplasmic Reticulum Stress-Induced Pathway.
Shi WY; Cao C; Liu L
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827850
[TBL] [Abstract][Full Text] [Related]
16. Absence of autophagy promotes apoptosis by modulating the ROS-dependent RLR signaling pathway in classical swine fever virus-infected cells.
Pei J; Deng J; Ye Z; Wang J; Gou H; Liu W; Zhao M; Liao M; Yi L; Chen J
Autophagy; 2016 Oct; 12(10):1738-1758. PubMed ID: 27463126
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics.
Bonavida B; Garban H
Redox Biol; 2015 Dec; 6():486-494. PubMed ID: 26432660
[TBL] [Abstract][Full Text] [Related]
18. Type I interferons in infectious disease.
McNab F; Mayer-Barber K; Sher A; Wack A; O'Garra A
Nat Rev Immunol; 2015 Feb; 15(2):87-103. PubMed ID: 25614319
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial division inhibitor 1 (mdivi-1) enhances death receptor-mediated apoptosis in human ovarian cancer cells.
Wang J; Hansen K; Edwards R; Van Houten B; Qian W
Biochem Biophys Res Commun; 2015 Jan; 456(1):7-12. PubMed ID: 25446129
[TBL] [Abstract][Full Text] [Related]
20. Aplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway.
Liu J; Ma L; Wu N; Liu G; Zheng L; Lin X
Mar Drugs; 2014 Sep; 12(9):5072-88. PubMed ID: 25257790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
